Adaptation to statins restricts human tumour growth in Nude mice

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Follet, Julie ^a   Rémy, Lionel ^b   Hesry, Vincent ^c   Simon, Brigitte ^a   Gillet, Danièle ^a   Auvray, Pierrick ^c   Corcos, Laurent ^a   Le Jossic Corcos, Catherine ^a  

^a UNIVERSITÉ EUROPÉENNE DE BRETAGNE   (France)

^b INSERM   (France)

^c Parc Technopolitain Atalante Saint Malo ^*  (France)

Author keywords

Angiogenesis; Apoptosis; Gastric cancer; Nude mice; Statins

Indexed keywords

CD34 ANTIGEN; COLLAGEN TYPE 4; CYCLIN B1; KALININ; MEVINOLIN; VASCULOTROPIN; CELL ADHESION MOLECULE; COLLAGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; VASCULOTROPIN A;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL ADHESION; CELL DIVISION; DRUG RESISTANCE; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR GROWTH; TUMOR VASCULARIZATION; ANIMAL; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; STOMACH TUMOR; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELL ADHESION MOLECULES; CELL DIVISION; COLLAGEN; CYCLIN B1; DRUG RESISTANCE, NEOPLASM; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOHISTOCHEMISTRY; LOVASTATIN; MICE; MICE, NUDE; REAL-TIME POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 81455162140     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-491     Document Type: Article

References (25)

1. Istvan ES, Deisenhofer J. Structural mechanism for statin inhibition of HMG-CoA reductase. Science 2001, 292:1160-1164. 10.1126/science.1059344, 11349148.
2. Endo A. The discovery and development of HMG-CoA reductase inhibitors. J Lipid Res 1992, 33:1569-1582.
3. Demierre MF, Higgins PD, Gruber SB, Hawk E, Lippman SM. Statins and cancer prevention. Nat Rev Cancer 2005, 5:930-942. 10.1038/nrc1751, 16341084.
4. Katz MS. Therapy insight: Potential of statins for cancer chemoprevention and therapy. Nat Clin Pract Oncol 2005, 2:82-89.
5. Bjerre LM, LeLorier J. Do statins cause cancer? A meta-analysis of large randomized clinical trials. Am J Med 2001, 110:716-723. 10.1016/S0002-9343(01)00705-7, 11403756.
6. Burkhardt R, Kenny EE, Lowe JK, Birkeland A, Josowitz R, Noel M, Salit J, Maller JB, Pe'er I, Daly MJ, et al. Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13. Arterioscler Thromb Vasc Biol 2008, 28:2078-2084. 10.1161/ATVBAHA.108.172288, 2764366, 18802019.
7. Hindler K, Cleeland CS, Rivera E, Collard CD. The role of statins in cancer therapy. Oncologist 2006, 11:306-315. 10.1634/theoncologist.11-3-306, 16549815.
8. Jakobisiak M, Golab J. Potential antitumor effects of statins (Review). Int J Oncol 2003, 23:1055-1069.
9. Fritz G, Kaina B. Rho GTPases: promising cellular targets for novel anticancer drugs. Curr Cancer Drug Targets 2006, 6:1-14.
10. Satoh K, Nakai T, Ichihara K. Influence of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on mitochondrial respiration in rat liver during ischemia. Eur J Pharmacol 1994, 270:365-369.
11. Gibot L, Follet J, Metges JP, Auvray P, Simon B, Corcos L, Le Jossic-Corcos C. Human caspase 7 is positively controlled by SREBP-1 and SREBP-2. Biochem J 2009, 420:473-483. 10.1042/BJ20082057, 19323650.
12. Logette E, Le Jossic-Corcos C, Masson D, Solier S, Sequeira-Legrand A, Dugail I, Lemaire-Ewing S, Desoche L, Solary E, Corcos L. Caspase-2, a novel lipid sensor under the control of sterol regulatory element binding protein 2. Mol Cell Biol 2005, 25:9621-9631. 10.1128/MCB.25.21.9621-9631.2005, 1265809, 16227610.
13. Laboisse CL, Augeron C, Couturier-Turpin MH, Gespach C, Cheret AM, Potet F. Characterization of a newly established human gastric cancer cell line HGT-1 bearing histamine H2-receptors. Cancer Res 1982, 42:1541-1548.
14. Bissery MC, Chabot GG. History and new development of screening and evaluation methods of anticancer drugs used in vivo and in vitro. Bull Cancer 1991, 78:587-602.
15. Nejjari M, Anderson W, Pourreyron C, Jacquier MF, Scoazec JY, Remy L. The role of fibroblasts in the modulation of integrin-dependent interactions between the gastric cell line HGT-1 and fibronectin. Int J Cancer 2004, 112:560-569. 10.1002/ijc.20444, 15382036.
16. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
17. Hotz MA, Bosq J, Zbaeren P, Reed J, Schwab G, Krajewski S, Brousset P, Borner MM. Spontaneous apoptosis and the expression of p53 and Bcl-2 family proteins in locally advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1999, 125:417-422.
18. Tsamandas AC, Kardamakis D, Tsiamalos P, Liava A, Tzelepi V, Vassiliou V, Petsas T, Vagenas K, Zolota V, Scopa CD. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome. Anticancer Res 2009, 29:703-709.
19. Warr MR, Shore GC. Unique biology of Mcl-1: therapeutic opportunities in cancer. Curr Mol Med 2008, 8:138-147. 10.2174/156652408783769580, 18336294.
20. Megha T, Lazzi S, Ferrari F, Vatti R, Howard CM, Cevenini G, Leoncini L, Luzi P, Giordano A, Tosi P. Expression of the G2-M checkpoint regulators cyclin B1 and P34CDC2 in breast cancer: a correlation with cellular kinetics. Anticancer Res 1999, 19:163-169.
21. Kawamoto H, Koizumi H, Uchikoshi T. Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses. Am J Pathol 1997, 150:15-23. 1858517, 9006317.
22. Kebebew E, Peng M, Reiff E, Duh QY, Clark OH, McMillan A. Diagnostic and prognostic value of cell-cycle regulatory genes in malignant thyroid neoplasms. World J Surg 2006, 30:767-774. 10.1007/s00268-005-0308-2, 16547620.
23. Fukudome Y, Yanagihara K, Takeichi M, Ito F, Shibamoto S. Characterization of a mutant E-cadherin protein encoded by a mutant gene frequently seen in diffuse-type human gastric carcinoma. Int J Cancer 2000, 88:579-583. 10.1002/1097-0215(20001115)88:4<579::AID-IJC10>3.0.CO;2-U, 11058874.
24. Shah MA, Kelsen DP. Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease. J Natl Compr Canc Netw 2010, 8:437-447.
25. Klawitter J, Shokati T, Moll V, Christians U. Effects of lovastatin on breast cancer cells: a proteo-metabonomic study. Breast Cancer Res 2010, 12:R16. 10.1186/bcr2485, 2879560, 20205716.